{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T12:45:11Z","timestamp":1775565911602,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009697","name":"Hashemite University","doi-asserted-by":"publisher","award":["54\/2020"],"award-info":[{"award-number":["54\/2020"]}],"id":[{"id":"10.13039\/501100009697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11777-z","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:48:05Z","timestamp":1775562485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Isorhamnetin alleviates fibromyalgia-like pain and mood deficits via monoaminergic, inflammatory, and TRPV1 pathways in mice"],"prefix":"10.1007","volume":"53","author":[{"given":"Abdelrahim","family":"Alqudah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esam","family":"Qnais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousra","family":"Bsieso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sireen Abdul Rahim","family":"Shilbayeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa A. A.","family":"Aljabali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad E.","family":"Rabeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad M.","family":"Rabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabaa Y.","family":"Athamneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"11777_CR1","unstructured":"Kaltsas G, Tsiveriotis K, Fibromyalgia (2023) Endotext. 1\u201332. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279092\/ (accessed September 23, 2025)"},{"key":"11777_CR2","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/J.PAIN.0000000000001939","volume":"161","author":"SN Raja","year":"2020","unstructured":"Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, Keefe FJ, Mogil JS, Ringkamp M, Sluka KA, Song XJ, Stevens B, Sullivan MD, Tutelman PR, Ushida T. Vader K (2020) The revised international association for the study of pain definition of pain: concepts, challenges, and compromises. Pain 161:1976\u20131982. https:\/\/doi.org\/10.1097\/J.PAIN.0000000000001939","journal-title":"Pain"},{"key":"11777_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.pop.2018.02.008","volume":"45","author":"JB Higgs","year":"2018","unstructured":"Higgs JB (2018) Fibromyalgia in Primary Care, Prim. Care - Clin. Off Pract 45:325\u2013341. https:\/\/doi.org\/10.1016\/j.pop.2018.02.008","journal-title":"Off Pract"},{"key":"11777_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4081\/reumatismo.2014.767","volume":"66","author":"G Cassisi","year":"2014","unstructured":"Cassisi G, Sarzi-Puttini P, Casale R, Cazzola M, Boccassini L, Atzeni F, Stisi S (2014) Pain in fibromyalgia and related conditions. Reumatismo 66:72\u201386. https:\/\/doi.org\/10.4081\/reumatismo.2014.767","journal-title":"Reumatismo"},{"key":"11777_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/J.JPAIN.2011.12.009","volume":"13","author":"RJ Anderson","year":"2012","unstructured":"Anderson RJ, McCrae CS, Staud R, Berry RB, Robinson ME (2012) Predictors of Clinical Pain in Fibromyalgia: Examining the Role of Sleep. J Pain 13:350\u2013358. https:\/\/doi.org\/10.1016\/J.JPAIN.2011.12.009","journal-title":"J Pain"},{"key":"11777_CR6","doi-asserted-by":"publisher","unstructured":"Alfaro-Rodr\u00edguez A, Reyes-Long S, Roldan-Valadez E, Gonz\u00e1lez-Torres M, Bonilla-Jaime H, Bandala C, Avila-Luna A, Bueno-Nava A, Cabrera-Ruiz E, Sanchez-Aparicio P, Gonz\u00e1lez Maciel A, Dotor-Llerena AL (2024) J.L. Cortes-altamirano, association of the serotonin and kynurenine pathways as possible therapeutic targets to modulate pain in patients with fibromyalgia. Pharm 17:17. https:\/\/doi.org\/10.3390\/ph17091205","DOI":"10.3390\/ph17091205"},{"key":"11777_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.semarthrit.2018.08.003","volume":"48","author":"R Grayston","year":"2019","unstructured":"Grayston R, Czanner G, Elhadd K, Goebel A, Frank B, \u00dc\u00e7eyler N, Malik RA, Alam U (2019) A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: Implications for a new paradigm in fibromyalgia etiopathogenesis, Semin. Arthritis Rheum 48:933\u2013940. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.08.003","journal-title":"Arthritis Rheum"},{"key":"11777_CR8","doi-asserted-by":"publisher","unstructured":"dos Santos JM, Lacerda ACR, Ribeiro VGC, Figueiredo PHS, Fonseca SF, Lage VK, Costa HS, Lima VP, Sa\u00f1udo B, Bernardo-Filho M, D. da C. de S\u00e1, Caputo VA, Mendon\u00e7a R, Taiardos Santos JM, Lacerda ACR, Ribeiro VGC, Figueiredo PHS, Fonseca SF, Lage VK, Costa HS, Lima VP, Sa\u00f1udo B, Bernardo-Filho M. da C. de S\u00e1 Caputo D. Mendon\u00e7a VA. Taiar R (2022) Oxidative stress biomarkers and quality of life are contributing factors of muscle pain and lean body mass in patients with Fibromyalgia, Biol 11:11. https:\/\/doi.org\/10.3390\/biology11060935","DOI":"10.3390\/biology11060935"},{"key":"11777_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/J.BBI.2018.09.018","volume":"75","author":"DS Albrecht","year":"2019","unstructured":"Albrecht DS, Forsberg A, Sandstr\u00f6m A, Bergan C, Kadetoff D, Protsenko E, Lampa J, Lee YC, H\u00f6glund CO, Catana C, Cervenka S, Akeju O, Lekander M, Cohen G, Halldin C, Taylor N, Kim M, Hooker JM, Edwards RR, Napadow V, Kosek E, Loggia ML (2019) Brain glial activation in fibromyalgia \u2013 A multi-site positron emission tomography investigation. Brain Behav Immun 75:72\u201383. https:\/\/doi.org\/10.1016\/J.BBI.2018.09.018","journal-title":"Brain Behav Immun"},{"key":"11777_CR10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/ANNRHEUMDIS-2016-209724","volume":"76","author":"GJ Macfarlane","year":"2017","unstructured":"Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, H\u00e4user W, Flub E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longle K, McCarthy GM, Makri S, Perrot S, Sarzi-Puttini P, Taylor A, Jones GT (2017) EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 76:318\u2013328. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2016-209724","journal-title":"Ann Rheum Dis"},{"key":"11777_CR11","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/S10067-022-06129-8\/TABLES\/4","volume":"41","author":"FF Alberti","year":"2022","unstructured":"Alberti FF, Becker MW, Blatt CR, Ziegelmann PK, da Silva Dal T, Pizzol D, Pilger (2022) Comparative efficacy of amitriptyline, duloxetine and pregabalin for treating fibromyalgia in adults: an overview with network meta-analysis. Clin Rheumatol 41:1965\u20131978. https:\/\/doi.org\/10.1007\/S10067-022-06129-8\/TABLES\/4","journal-title":"Clin Rheumatol"},{"key":"11777_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4081\/reumatismo.2012.268","volume":"64","author":"A Alciati","year":"2012","unstructured":"Alciati A, Sgiarovello P, Atzeni F, Sarzi-Puttini P (2012) Psychiatric problems in fibromyalgia: clinical and neurobiological links between mood disorders and fibromyalgia. Reumatismo 64:268\u2013274","journal-title":"Reumatismo"},{"key":"11777_CR13","doi-asserted-by":"publisher","unstructured":"Hu N, Liu J, Luo Y, Li Y (2024) A comprehensive review of traditional Chinese medicine in treating neuropathic pain. Heliyon 10. https:\/\/doi.org\/10.1016\/j.heliyon.210.1016\/j.heliyon.2024.e37350","DOI":"10.1016\/j.heliyon.210.1016\/j.heliyon.2024.e37350"},{"key":"11777_CR14","doi-asserted-by":"publisher","unstructured":"Wei PC, Lee-Chen GJ, Chen CM, Chen Y, Lo YS, Chang KH (2022) Isorhamnetin attenuated the release of interleukin-6 from \u03b2 -amyloid-activated microglia and mitigated interleukin-6-mediated neurotoxicity, Oxid Med Cell Longev https:\/\/doi.org\/10.1155\/2022\/3652402","DOI":"10.1155\/2022\/3652402"},{"key":"11777_CR15","doi-asserted-by":"publisher","unstructured":"Xu SL, Choi RCY, Zhu KY, Leung KW, Guo AJY, Bi D, Xu H, Lau DTW, Dong TTX, Tsim KWK (2012) Isorhamnetin, a flavonol aglycone from Ginkgo biloba L., induces neuronal differentiation of cultured PC12 cells: Potentiating the effect of nerve growth factor. Evidence-Based Complement Altern Med https:\/\/doi.org\/10.1155\/2012\/278273","DOI":"10.1155\/2012\/278273"},{"key":"11777_CR16","doi-asserted-by":"publisher","unstructured":"Mulati A, Zhang X, Zhao T, Ren B, Wang L, Liu X, Lan Y, Liu X (2024) Isorhamnetin attenuates highfat and high-fructose diet induced cognitive impairments and neuroinflammation by mediating MAPK and NF\u03baB signaling pathways. Food Funct 12(19):9261-9272. https:\/\/doi.org\/10.1039\/d0fo03165h","DOI":"10.1039\/d0fo03165h"},{"key":"11777_CR17","doi-asserted-by":"publisher","unstructured":"Dixon Clarke SE, Ramsay RR (2011) Dietary inhibitors of monoamine oxidase A. J Neural Transm (Vienna). 18(7):1031-41. https:\/\/doi.org\/10.1007\/s00702-010-0537-x","DOI":"10.1007\/s00702-010-0537-x"},{"key":"11777_CR18","doi-asserted-by":"publisher","first-page":"101709","DOI":"10.1016\/J.JCHEMNEU.2019.101709","volume":"102","author":"N Jamali-Raeufy","year":"2019","unstructured":"Jamali-Raeufy N, Baluchnejadmojarad T, Roghani M, keimasi S, goudarzi M (2019) Isorhamnetin exerts neuroprotective effects in STZ-induced diabetic rats via attenuation of oxidative stress, inflammation and apoptosis. J Chem Neuroanat 102:101709. https:\/\/doi.org\/10.1016\/J.JCHEMNEU.2019.101709","journal-title":"J Chem Neuroanat"},{"key":"11777_CR19","doi-asserted-by":"publisher","first-page":"110301","DOI":"10.1016\/J.BIOPHA.2020.110301","volume":"128","author":"G Gong","year":"2020","unstructured":"Gong G, Guan YY, Zhang ZL, Rahman K, Wang SJ, Zhou S, Luan X, Zhang H (2020) Isorhamnetin: A review of pharmacological effects. Biomed Pharmacother 128:110301. https:\/\/doi.org\/10.1016\/J.BIOPHA.2020.110301","journal-title":"Biomed Pharmacother"},{"key":"11777_CR20","doi-asserted-by":"publisher","unstructured":"Dong X, Li J-J, Ma N, Liu A-Z, Liu J-W (2022) Anti-inflammatory and anti-oxidative effects of isorhamnetin for protection against lung injury in a rat model of heatstroke in a dry-heat environment. Med Sci Monit 28. https:\/\/doi.org\/10.12659\/MSM.935426","DOI":"10.12659\/MSM.935426"},{"key":"11777_CR21","doi-asserted-by":"publisher","first-page":"7668","DOI":"10.3390\/CIMB45090484","volume":"45","author":"O Gammoh","year":"2023","unstructured":"Gammoh O, Qnais EY, Athamneh RY, Al-Jaidi B, Al-Tawalbeh D, Altaber S, Alqudah A, Aljabali AAA, Tambuwala MM (2023) Unraveling the potential of isorhamnetin as an adjuvant in depression treatment with escitalopram, Curr Issues Mol Biol 45:7668\u20137679. https:\/\/doi.org\/10.3390\/CIMB45090484","journal-title":"Issues Mol Biol 2023"},{"key":"11777_CR22","doi-asserted-by":"publisher","unstructured":"Alqudah A, Qnais E, Bsieso Y, Gammoh O, Aljabali AAA, Shilbayeh SAR (2025) Neuroprotective and antidepressant effects of isorhamnetin: mechanistic evaluations in a reserpine-induced mouse model of pain and depression. Mol Neurobiol 1\u201315. https:\/\/doi.org\/10.1007\/s12035-025-05244-2","DOI":"10.1007\/s12035-025-05244-2"},{"key":"11777_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/J.PAIN.2009.05.024","volume":"146","author":"Y Nagakura","year":"2009","unstructured":"Nagakura Y, Oe T, Aoki T, Matsuoka N (2009) Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia. Pain 146:26\u201333. https:\/\/doi.org\/10.1016\/J.PAIN.2009.05.024","journal-title":"Pain"},{"key":"11777_CR24","doi-asserted-by":"publisher","first-page":"173870","DOI":"10.1016\/J.EJPHAR.2021.173870","volume":"895","author":"I Brusco","year":"2021","unstructured":"Brusco I, Justino AB, Silva CR, Scussel R, Machado-de-\u00c1vila RA, Oliveira SM (2021) Inhibitors of angiotensin I converting enzyme potentiate fibromyalgia-like pain symptoms via kinin receptors in mice. Eur J Pharmacol 895:173870. https:\/\/doi.org\/10.1016\/J.EJPHAR.2021.173870","journal-title":"Eur J Pharmacol"},{"key":"11777_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55\u201363. https:\/\/doi.org\/10.1016\/0165-0270(94)90144-9","journal-title":"J Neurosci Methods"},{"key":"11777_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/ANNUREV.PA.20.040180.002301\/CITE\/REFWORKS","volume":"20","author":"WJ Dixon","year":"1980","unstructured":"Dixon WJ (1980) Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20:441\u2013462. https:\/\/doi.org\/10.1146\/ANNUREV.PA.20.040180.002301\/CITE\/REFWORKS","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"11777_CR27","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1007\/S10787-024-01473-4\/METRICS","volume":"32","author":"LP Marquezin","year":"2024","unstructured":"Marquezin LP, Fialho MFP, Favarin A, de Lara JD, Pillat MM, Rosemberg DB, Oliveira SM (2024) Diosmetin attenuates fibromyalgia-like symptoms in a reserpine-induced model in mice. Inflammopharmacology 32:2601\u20132611. https:\/\/doi.org\/10.1007\/S10787-024-01473-4\/METRICS","journal-title":"Inflammopharmacology"},{"key":"11777_CR28","doi-asserted-by":"publisher","unstructured":"Can A, Dao DT, Arad M, Terrillion CE, Piantadosi SC, Gould TD (2012) The mouse forced swim test. J Vis Exp 3638. https:\/\/doi.org\/10.3791\/3638","DOI":"10.3791\/3638"},{"key":"11777_CR29","doi-asserted-by":"publisher","unstructured":"Walf AA, Frye CA (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2:322\u2013328. https:\/\/doi.org\/10.1038\/NPROT.2007.44;KWRD=LIFE+SCIENCES","DOI":"10.1038\/NPROT.2007.44;KWRD=LIFE+SCIENCES"},{"key":"11777_CR30","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1097\/J.PAIN.0000000000001051","volume":"158","author":"SL Casey","year":"2017","unstructured":"Casey SL, Atwal N, Vaughan CW (2017) Cannabis constituent synergy in a mouse neuropathic pain model. Pain 158:2452\u20132460. https:\/\/doi.org\/10.1097\/J.PAIN.0000000000001051","journal-title":"Pain"},{"key":"11777_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11916-016-0556-X\/METRICS","volume":"20","author":"S Chinn","year":"2016","unstructured":"Chinn S, Caldwell W, Gritsenko K (2016) Fibromyalgia pathogenesis and treatment options update. Curr Pain Headache Rep 20:1\u201310. https:\/\/doi.org\/10.1007\/S11916-016-0556-X\/METRICS","journal-title":"Pain Headache Rep"},{"key":"11777_CR32","doi-asserted-by":"publisher","first-page":"891748","DOI":"10.1155\/2013\/891748","volume":"2013","author":"KS Bhullar","year":"2013","unstructured":"Bhullar KS, Rupasinghe HPV (2013) Polyphenols: multipotent therapeutic agents in neurodegenerative diseases. Oxid Med Cell Longev 2013:891748. https:\/\/doi.org\/10.1155\/2013\/891748","journal-title":"Oxid Med Cell Longev"},{"key":"11777_CR33","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1097\/J.PAIN.0000000000002927","volume":"164","author":"C Mueller","year":"2023","unstructured":"Mueller C, Fang YHD, Jones C, McConathy JE, Raman F, Lapi SE, Younger JW (2023) Evidence of neuroinflammation in fibromyalgia syndrome: a [18F]DPA-714 positron emission tomography study. Pain 164:2285\u20132295. https:\/\/doi.org\/10.1097\/J.PAIN.0000000000002927","journal-title":"Pain"},{"key":"11777_CR34","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1080\/08923973.2019.1641723","volume":"41","author":"S-W Tsai","year":"2019","unstructured":"Tsai S-W, Lin C-C, Lin S-C, Wang S-P, Yang D-H (2019) Isorhamnetin ameliorates inflammatory responses and articular cartilage damage in the rats of monosodium iodoacetate-induced osteoarthritis. Immunopharmacol Immunotoxicol 41:504\u2013512. https:\/\/doi.org\/10.1080\/08923973.2019.1641723","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"11777_CR35","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.26355\/eurrev_202408_36672","volume":"28","author":"A Alqudah","year":"2024","unstructured":"Alqudah A, Qnais E, Bseiso Y, Gammoh O, Wedyan M, Oqal M, AbuDalo R, Alotaibi B (2024) Exploring the analgesic potential of isorhamnetin: insights from formalin-induced pain and diabetic neuropathy models. Eur Rev Med Pharmacol Sci 28:4214\u20134224. https:\/\/doi.org\/10.26355\/eurrev_202408_36672","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"11777_CR36","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/FJ.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659\u2013661. https:\/\/doi.org\/10.1096\/FJ.07-9574LSF","journal-title":"FASEB J"},{"key":"11777_CR37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.fitote.2014.01.013","volume":"93","author":"Y Xie","year":"2014","unstructured":"Xie Y, Luo H, Duan J, Hong C, Ma P, Li G, Zhang T, Wu T, Ji G (2014) Phytic acid enhances the oral absorption of isorhamnetin, quercetin, and kaempferol in total flavones of Hippophae rhamnoides L. Fitoterapia 93:216\u2013225. https:\/\/doi.org\/10.1016\/j.fitote.2014.01.013","journal-title":"Fitoterapia"},{"key":"11777_CR38","doi-asserted-by":"publisher","first-page":"116860","DOI":"10.1016\/J.BIOPHA.2024.116860","volume":"176","author":"P Biswas","year":"2024","unstructured":"Biswas P, Kaium MA, Islam Tareq MM, Tauhida SJ, Hossain MR, Siam LS, Parvez A, Bibi S, Hasan MH, Rahman MM, Hosen D, Islam Siddiquee MA, Ahmed N, Sohel M, Al Azad S, Alhadrami AH, Kamel M, Alamoudi MK, Hasan MN (2024) Abdel-Daim, The experimental significance of isorhamnetin as an effective therapeutic option for cancer: A comprehensive analysis. Biomed Pharmacother 176:116860. https:\/\/doi.org\/10.1016\/J.BIOPHA.2024.116860","journal-title":"Biomed Pharmacother"},{"key":"11777_CR39","doi-asserted-by":"publisher","unstructured":"De Aquino AB, Cavalcante-Silva LHA, Da Matta CBB, Epif\u00e2nio WADN, Aquino PGV, Santana AEG, Alexandre-Moreira MS, De Ara\u00fajo-J\u00fanior JX (2013) The antinociceptive and anti-inflammatory activities of aspidosperma tomentosum (apocynaceae), sci. World J 218627. https:\/\/doi.org\/10.1155\/2013\/218627","DOI":"10.1155\/2013\/218627"},{"key":"11777_CR40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/J.FCT.2013.05.049","volume":"59","author":"JH Yang","year":"2013","unstructured":"Yang JH, Kim SC, Shin BY, Jin SH, Jo MJ, Jegal KH, Kim YW, Lee JR, Ku SK, Cho IJ, Ki SH (2013) O-methylated flavonol isorhamnetin prevents acute inflammation through blocking of NF-\u03baB activation. Food Chem Toxicol 59:362\u2013372. https:\/\/doi.org\/10.1016\/J.FCT.2013.05.049","journal-title":"Food Chem Toxicol"},{"key":"11777_CR41","doi-asserted-by":"publisher","unstructured":"Xu M, He W, Yan K, Gao X, Li J, Xu D, Xiao J, Yan T (2025) Isorhamnetin Alleviates Inflammation-Induced Crosstalk between Kynurenine Pathway and Gut Microbiota in Depressed Mice. Biomol Ther (Seoul). 33(2):297-310. https:\/\/doi.org\/10.4062\/biomolther.2024.061","DOI":"10.4062\/biomolther.2024.061"},{"key":"11777_CR42","doi-asserted-by":"publisher","unstructured":"Aquino AB, CavalcanteSilva LH, Matta CB, Epif\u00e2nio WA, Aquino PG, Santana AE, Alexandre-Moreira MS, de Ara\u00fajo-J\u00fanior JX (2013) The antinociceptive and anti-inflammatory activities of Aspidosperma tomentosum (Apocynaceae). Scientific World Journal. https:\/\/doi.org\/10.1155\/2013\/218627","DOI":"10.1155\/2013\/218627"},{"key":"11777_CR43","doi-asserted-by":"publisher","unstructured":"Shi H, He J, Li X, Han J, Wu R, Wang D, Yang F, Sun E (2018) Isorhamnetin, the active constituent of a Chinese herb Hippophae rhamnoides L, is a potent suppressor of dendritic-cell maturation and trafficking. Int Immunopharmacol. 55:216-222. https:\/\/doi.org\/10.1016\/j.intimp.2017.12.014","DOI":"10.1016\/j.intimp.2017.12.014"},{"key":"11777_CR44","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/S00296-017-3725-2\/METRICS","volume":"37","author":"F Heidari","year":"2017","unstructured":"Heidari F, Afshari M, Moosazadeh M (2017) Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol Int 37:1527\u20131539. https:\/\/doi.org\/10.1007\/S00296-017-3725-2\/METRICS","journal-title":"Rheumatol Int"},{"key":"11777_CR45","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","volume":"17","author":"LP Queiroz","year":"2013","unstructured":"Queiroz LP (2013) Worldwide Epidemiology of Fibromyalgia, Curr. Pain Headache Rep 17:356. https:\/\/doi.org\/10.1007\/s11916-013-0356-5","journal-title":"Pain Headache Rep"},{"key":"11777_CR46","doi-asserted-by":"publisher","first-page":"105749","DOI":"10.1016\/j.neubiorev.2024.105749","volume":"163","author":"JS Mogil","year":"2024","unstructured":"Mogil JS, Parisien M, Esfahani SJ, Diatchenko L (2024) Sex differences in mechanisms of pain hypersensitivity. Neurosci Biobehav Rev 163:105749. https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105749","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11777-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11777-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11777-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:48:06Z","timestamp":1775562486000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11777-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11777"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11777-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental procedures were conducted in accordance with the ARRIVE 2.0 guidelines and were approved by the Institutional Review Board (IRB) of The Hashemite University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"598"}}